Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-20-250596
Filing Date
2020-09-22
Accepted
2020-09-22 06:31:23
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d42636dsctota.htm SC TO-T/A 31811
2 EXHIBIT (A)(5)(G) d42636dex99a5g.htm EX-99.(A)(5)(G) 15567
3 GRAPHIC g42636g0921194430848.jpg GRAPHIC 2535
  Complete submission text file 0001193125-20-250596.txt   52719
Mailing Address 54 RUE LA BOETIE PARIS I0 75008
Business Address 54 RUE LA BOETIE PARIS I0 75008 33153774400
Sanofi (Filed by) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 220 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-7700
Principia Biopharma Inc. (Subject) CIK: 0001510487 (see all company filings)

IRS No.: 263487603 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-90643 | Film No.: 201187838
SIC: 2834 Pharmaceutical Preparations